Buy Piramal Enterprises, target Rs 3,000: Dr CK Narayan
Buy Piramal Enterprises Ltd. at a price target of Rs 3000.0 and a stoploss at Rs 2600 from entry point.

Piramal Enterprises Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 1875.78 Crore to Sales Value (49.24 % of Total Sales), Interest which contributed Rs 1483.56 Crore to Sales Value (38.94 % of Total Sales), Sale of services which contributed Rs 205.04 Crore to Sales Value (5.38 % of Total Sales), Income From Financial Services which contributed Rs 146.91 Crore to Sales Value (3.85 % of Total Sales), Other Operating Revenue which contributed Rs 54.37 Crore to Sales Value (1.42 % of Total Sales), Dividend which contributed Rs 40.77 Crore to Sales Value (1.07 % of Total Sales), Processing Charges which contributed Rs 2.88 Crore to Sales Value (0.07 % of Total Sales)for the year ending 31-Mar-2017.
For the quarter ended 30-06-2018, the company has reported a Consolidated sales of Rs 2902.49 Crore, down -2.96 % from last quarter Sales of Rs 2991.06 Crore and up 29.24 % from last year same quarter Sales of Rs 2245.75 Crore Company has reported net profit after tax of Rs -130.04 Crore in latest quarter. The company’s top management includes Dr.Raghunath Mashelkar, Dr.(Mrs.)Swati Piramal, Mr.Ajay Piramal, Mr.Anand Piramal, Mr.Deepak M Satwalekar, Mr.Gautam Banerjee, Mr.Keki Dadiseth, Mr.Narayanan Vaghul, Mr.S Ramadorai, Mr.Siddharth (Bobby) Mehta, Mr.Vijay Shah, Ms.Nandini Piramal, Prof.Goverdhan Mehta. Company has Price Waterhouse as its auditoRs As on 30-06-2018, the company has a total of 180,592,514 shares outstanding.
Download ET Markets APP